LifeVantage Introduces Canine Health Product

LifeVantage Introduces Canine Health Product

The Only Pet Supplement Specifically Formulated to Reduce Oxidative Stress
Through Nrf2 Activation in Dogs

SALT LAKE CITY, Jan. 22, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, including its patented dietary supplement Protandim^®, the
Nrf2 Synergizer^®, introduced at its Elite Academy in San Antonio its newest
healthy living product, Canine Health, a supplement specifically formulated
for dogs to combat oxidative stress through Nrf2 activation. The product is
also formulated to support joint function, mobility, flexibility and cognitive
function.

The Canine Health product was developed by LifeVantage in conjunction with
renowned veterinarian and authority on animal nutrition, William Barnett, DVM,
who has nearly 40 years of experience in veterinary medicine and in bringing
products to market designed to improve animal health. Canine Health includes
the same natural active ingredients as Protandim, at dosage levels
specifically formulated for dogs, as well as omega-3 fatty acids and Type II
collagen. These ingredients have been shown to reduce oxidative stress,
support brain, heart and eye function, as well as normal joint structure and
function.

"Protandim was developed to promote healthy living by helping people reduce
age-related symptoms at the cellular level," said LifeVantage President and
Chief Executive Officer Douglas C. Robinson. "Like humans, dogs suffer from
oxidative stress, and research shows that canine companions can benefit from
the same active ingredients contained in our patented flagship product,
Protandim.

"Canine Health has been clinically tested in collaboration with Dr. Craig
Woods, DVM, of Animal Health Consultants in Prescott, Arizona in a
double-blind, placebo-controlled, multi-site study that demonstrates the
safety and benefits of the product." Robinson added, "We have also gone a step
further—adding vital ingredients already widely used to maintain pet health—to
make Canine Health a convenient, all-in-one supplement and the only product in
the world that is specifically formulated to treat oxidative stress in pets."

According to a leading authority on oxidative stress in pets, Dr. Maureen
McMichael, DVM, DACVECC, Associate Professor of Veterinary Medicine at the
University of Illinois, "LifeVantage Canine Health meets all criteria for a
safe, easily administered, appealing product that targets multiple oxidative
stress pathways in canines. My primary research focus has been the cause and
treatment of oxidative stress in animals and humans so I am very excited to
recommend this product to pet owners. Based on my research and on statistics
from the American Pet Products Association, which show 39 percent of U.S.
households have dogs—numbering more than 78 million—I believe there is a great
need for Canine Health among pets."

LifeVantage products, including Canine Health, which is available for purchase
effective immediately, are sold through a network of LifeVantage Independent
Distributors. LifeVantage is a proud member of The National Animal Supplement
Council (NASC), a trade association dedicated to protecting and enhancing the
health of companion animals committed to the highest standards of quality for
animal supplements.

About LifeVantage Corporation

LifeVantage (Nasdaq:LFVN), a leader in Nrf2 science and the maker of
Protandim^®, the Nrf2 Synergizer^® patented dietary supplement, is a science
based nutraceutical company. LifeVantage is dedicated to visionary science
that looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City, Utah.

The LifeVantage Corporation logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=11617

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
Words and expressions reflecting optimism and satisfaction with current
prospects, as well as words such as "believe," "anticipates," "look forward
to," "should" and variations thereof, identify forward-looking statements, but
their absence does not mean that a statement is not forward-looking. Examples
of forward-looking statements include, but are not limited to, statements we
make regarding the demand for, the expected safety and the benefits of Canine
Health in dogs. Such forward-looking statements are not guarantees of
performance and the Company's actual results could differ materially from
those contained in such statements. These forward-looking statements are based
on the Company's current expectations and beliefs concerning future events
affecting the Company and involve known and unknown risks and uncertainties
that may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks and
uncertainties include, among others, the Company's inability to successfully
expand our operations in existing and other markets and thereafter manage our
growth; the Company's ability to retain independent distributors or to attract
new independent distributors on an ongoing basis; the Company's ability to
expand its product offerings; violations of law or our procedures by the
Company's independent distributors; the potential for third-party and
governmental actions involving the Company's network marketing efforts; the
potential for product liability claims against the Company; the risk that
government regulators and regulations could adversely affect the Company's
business; future laws or regulations may hinder or prohibit the production or
sale of the Company's existing product and any future products; unfavorable
publicity could materially hurt the Company's business; the Company's ability
to access raw materials for its Products as it grows; and the Company's
ability to protect its intellectual property rights and the value of its
product. These and other risk factors are discussed in greater detail in the
Company's Annual Report on Form 10-K and its Quarterly Report on Form 10-Q
under the caption "Risk Factors," and in other documents filed by the Company
from time to time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the forward-looking
statements contained in this document. All forward-looking statements are
based on information currently available to the Company on the date hereof,
and the Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after the date
of this document, except as required by law.

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         -or-
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo
 
Press spacebar to pause and continue. Press esc to stop.